David Fenton

4.8k total citations
38 papers, 1.2k citations indexed

About

David Fenton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, David Fenton has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in David Fenton's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). David Fenton is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lung Cancer Research Studies (4 papers). David Fenton collaborates with scholars based in Canada, United Kingdom and United States. David Fenton's co-authors include Frances A. Shepherd, Mauro Zukin, Lesley Seymour, Francis Laberge, Jonathan Noble, Charles Butts, Andrew Arnold, Michael Smylie, Peter Ellis and Scott A. Laurie and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

David Fenton

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Fenton Canada	16	750	678	253	161	96	38	1.2k
Paul Rebattu France	17	580 0.8×	440 0.6×	150 0.6×	72 0.4×	47 0.5×	56	943
Ann Setser United States	9	456 0.6×	250 0.4×	167 0.7×	118 0.7×	44 0.5×	11	1.0k
Christine M. Bestvina United States	13	495 0.7×	315 0.5×	117 0.5×	87 0.5×	105 1.1×	65	966
Anna Ceribelli Italy	15	577 0.8×	449 0.7×	159 0.6×	53 0.3×	132 1.4×	35	1.0k
Perran Fulden Yumuk Türkiye	17	588 0.8×	386 0.6×	147 0.6×	197 1.2×	134 1.4×	101	1.0k
Jeong‐Seon Ryu South Korea	22	558 0.7×	772 1.1×	563 2.2×	136 0.8×	260 2.7×	121	1.5k
Anna Efremidis Greece	21	602 0.8×	420 0.6×	180 0.7×	156 1.0×	134 1.4×	59	1.0k
Peter Klare Germany	19	754 1.0×	372 0.5×	147 0.6×	82 0.5×	207 2.2×	89	1.3k
Elisabeth Jones United States	5	280 0.4×	309 0.5×	206 0.8×	162 1.0×	62 0.6×	5	1.0k
P. Mongiat-Artus France	23	309 0.4×	876 1.3×	310 1.2×	107 0.7×	176 1.8×	119	1.6k

Countries citing papers authored by David Fenton

Since Specialization

Citations

This map shows the geographic impact of David Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fenton more than expected).

Fields of papers citing papers by David Fenton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fenton. The network helps show where David Fenton may publish in the future.

Co-authorship network of co-authors of David Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of David Fenton. A scholar is included among the top collaborators of David Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fenton. David Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bigras, Gilbert, et al.. (2025). Impact of early discontinuation of adjuvant endocrine therapy on survival in breast cancer: A target trial emulation. European Journal of Cancer. 227. 115665–115665.

LeVasseur, Nathalie, David Fenton, Simon W. Baxter, et al.. (2021). Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study. Clinical Breast Cancer. 22(1). e74–e79. 9 indexed citations

Ksienski, Doran, Elaine S. Wai, Deepu Alex, et al.. (2021). Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab. Translational Lung Cancer Research. 10(1). 355–367. 34 indexed citations

Ksienski, Doran, Elaine S. Wai, Nicole S. Croteau, et al.. (2020). Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumab. Journal of Geriatric Oncology. 11(5). 807–813. 21 indexed citations

Ksienski, Doran, Elaine S. Wai, Nicole S. Croteau, et al.. (2019). Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practice. Lung Cancer. 133. 110–116. 36 indexed citations

Joe, Howard, et al.. (2018). Resolution of Metastatic Colon Cancer upon Withdrawal of Anti-TNF Therapy for Crohn’s Disease. Journal of Gastrointestinal Cancer. 50(3). 665–667. 1 indexed citations

Chu, Michael P., Sunita Ghosh, Carole Chambers, et al.. (2014). Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 16(1). 33–39. 80 indexed citations

Li, Xue, Andrew Scarfe, Karen King, et al.. (2013). Timeliness of cancer care from diagnosis to treatment: a comparison between patients with breast, colon, rectal or lung cancer. International Journal for Quality in Health Care. 25(2). 197–204. 30 indexed citations

Joseph, Kurian, et al.. (2012). Outcome analysis of breast cancer patients who declined evidence-based treatment. World Journal of Surgical Oncology. 10(1). 118–118. 54 indexed citations

10.

Yee, Don, Charles Butts, Tony Reiman, et al.. (2011). Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiotherapy and Oncology. 102(2). 234–238. 67 indexed citations

11.

Peddle‐McIntyre, Carolyn J., Gordon J. Bell, David Fenton, Linda McCargar, & Kerry S. Courneya. (2011). Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors. Lung Cancer. 75(1). 126–132. 60 indexed citations

12.

Fenton, David, et al.. (2010). Fallopian tube carcinoma presenting with an abnormal glandular smear. Journal of Obstetrics and Gynaecology. 30(3). 321–322. 2 indexed citations

13.

Goss, Glenwood, Andrew Arnold, Frances A. Shepherd, et al.. (2009). Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study. Journal of Clinical Oncology. 28(1). 49–55. 186 indexed citations

14.

Lynch, Thomas J., David Fenton, Vera Hirsh, et al.. (2007). Randomized phase II study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 7680–7680. 5 indexed citations

15.

Bezjak, Andrea, Dongsheng Tu, Lesley Seymour, et al.. (2006). Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. Journal of Clinical Oncology. 24(24). 3831–3837. 239 indexed citations

16.

Fenton, David, Sunil Verma, Peter Venner, Ravinder Sawhney, & John R. Mackey. (2002). The Lack of Long-Term Effect of Cisplatin Based Combination Chemotherapy on Serum Cholesterol for Treatment of Testicular Cancer. The Journal of Urology. 168(5). 1971–1974. 8 indexed citations

17.

Fenton, David, et al.. (1994). A case controlled study of the outcome of pregnancy following loop diathermy excision of the transformation zone. Journal of Obstetrics and Gynaecology. 14(2). 79–82. 25 indexed citations

18.

Anderson, Deverick J. & David Fenton. (1990). Management of severe secondary postpartum haemorrhage. Journal of Obstetrics and Gynaecology. 10(3). 225–226. 1 indexed citations

19.

Crawford, Diane, et al.. (1985). Ultrasonic tissue characterization of the placenta: Is it of clinical value?. Journal of Clinical Ultrasound. 13(8). 533–537. 11 indexed citations

20.

Fenton, David, et al.. (1985). DOES CERVICAL RIPENING WITH PGE₂ AFFECT SUBSEQUENT UTERINE ACTIVITY IN LABOUR?. Acta Obstetricia Et Gynecologica Scandinavica. 64(1). 27–30. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact